Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/5494
Title: Small Molecule Inhibitors Targeting HIV-1 Reverse Transcriptase Dimerization.
Authors: Grohmann, D
Corradi, V
Elbasyouny, M
Baude, A
Horenkamp, F
LAUFER S., D
Manetti, Fabrizio 
Botta, Maurizio 
Restle, T.
Issue Date: 2008
Project: None 
Journal: CHEMBIOCHEM
Abstract: 
The enzymatic activities of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) are strictly correlated with the dimeric forms of this vital retroviral enzyme. Accordingly, the development of inhibitors targeting the dimerization of RT represents a promising alternative antiviral strategy. Based on mutational studies, we applied a structure-based ligand design approach generating pharmacophoric models of the large subunit connection subdomain to possibly identify small molecules from the ASINEX database, which might interfere with the RT subunit interaction. Docking studies of the selected compounds identified several candidates, which were initially tested in an in vitro subunit association assay. One of these molecules (MAS0) strongly reduced the association of the two RT subunits p51 and p66. Most notably, the compound simultaneously inhibited both the polymerase as well as the RNase H activity of the retroviral enzyme, following preincubation with t(1/2) of about 2 h, indicative of a slow isomerization step. This step most probably represents a shift of the RT dimer equilibrium from an active to an inactive conformation. Taken together, to the best of our knowledge, this study represents the first successful rational screen for a small molecule HIV RT dimerization inhibitor, which may serve as attractive hit compound for the development of novel therapeutic agents.
Description: 
38271
URI: http://hdl.handle.net/20.500.12779/5494
ISSN: 1439-4227
DOI: 10.1002/cbic.200700669
Appears in Collections:Publications

Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.